Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
3449 | 1526 | 32.1 | 83% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
316 | 3 | RHEUMATOLOGY//RHEUMATOID ARTHRITIS//RHEUMATOL | 39766 |
3449 | 2 | INFLIXIMAB//ETANERCEPT//ADALIMUMAB | 1526 |
14378 | 1 | IMMUNODEFICIENCY ASSOCIATED LYMPHOPROLIFERATIVE DISORDERS//LYMPHOPROLIFERATIVE DISORDERS//METHOTREXATE | 773 |
16155 | 1 | INFLIXIMAB//DRUG INDUCED LUPUS//ADALIMUMAB | 670 |
36316 | 1 | HSPA12B//HEAT SHOCK PROTEIN A12B//INFLAMMATION AMPLIFIER | 83 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | INFLIXIMAB | authKW | 228399 | 11% | 7% | 175 |
2 | ETANERCEPT | authKW | 157657 | 7% | 8% | 104 |
3 | ADALIMUMAB | authKW | 152030 | 6% | 8% | 93 |
4 | DRUG INDUCED LUPUS | authKW | 140513 | 2% | 29% | 24 |
5 | HSPA12B | authKW | 108931 | 0% | 78% | 7 |
6 | HEAT SHOCK PROTEIN A12B | authKW | 100042 | 0% | 100% | 5 |
7 | TNF ALPHA ANTAGONISTS | authKW | 82050 | 1% | 22% | 19 |
8 | RHEUMATOLOGY | WoSSC | 67716 | 38% | 1% | 583 |
9 | IMMUNOMEDIATED HEPATITIS | authKW | 60025 | 0% | 100% | 3 |
10 | INFLAMMATION AMPLIFIER | authKW | 60025 | 0% | 100% | 3 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Rheumatology | 67716 | 38% | 1% | 583 |
2 | Dermatology | 3854 | 12% | 0% | 190 |
3 | Gastroenterology & Hepatology | 671 | 7% | 0% | 108 |
4 | Medicine, General & Internal | 392 | 9% | 0% | 137 |
5 | Oncology | 277 | 9% | 0% | 138 |
6 | Pathology | 161 | 4% | 0% | 55 |
7 | Immunology | 117 | 6% | 0% | 93 |
8 | Hematology | 82 | 3% | 0% | 47 |
9 | Pharmacology & Pharmacy | 17 | 5% | 0% | 74 |
10 | Medicine, Research & Experimental | 9 | 2% | 0% | 33 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PATHOL C2 | 40017 | 0% | 100% | 2 |
2 | RHEUMATOL | 39866 | 19% | 1% | 283 |
3 | DEV IMMUNOLJST C T | 26676 | 0% | 67% | 2 |
4 | UNIT INFLAMMATORY BOWEL DIS | 22506 | 0% | 38% | 3 |
5 | ABT RHEUMATOL FRAUNHOFER IMEPROJEKTGRP TRANSLA | 20008 | 0% | 100% | 1 |
6 | ADV THER EAUT ARTHRIT | 20008 | 0% | 100% | 1 |
7 | ALLERGY CLIN IMMUNOL RHEUMATOL UNIT INTERN | 20008 | 0% | 100% | 1 |
8 | ALLGEMEIN OFFENTL KRANKENHAUS | 20008 | 0% | 100% | 1 |
9 | AOU G MARTINO POLICLIN | 20008 | 0% | 100% | 1 |
10 | ARBEITSBEREICH PNEUMOL ONKOL | 20008 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CLINICAL RHEUMATOLOGY | 11711 | 4% | 1% | 56 |
2 | ANNALS OF THE RHEUMATIC DISEASES | 11278 | 5% | 1% | 71 |
3 | JOURNAL OF CROHNS & COLITIS | 9602 | 1% | 2% | 22 |
4 | LUPUS | 8924 | 3% | 1% | 41 |
5 | MODERN RHEUMATOLOGY | 8218 | 2% | 2% | 23 |
6 | RHEUMATOLOGY INTERNATIONAL | 7040 | 3% | 1% | 40 |
7 | JCR-JOURNAL OF CLINICAL RHEUMATOLOGY | 6513 | 1% | 1% | 22 |
8 | JOURNAL OF RHEUMATOLOGY | 5211 | 4% | 0% | 58 |
9 | RHEUMATOLOGY | 3797 | 2% | 1% | 30 |
10 | ARTHRITIS AND RHEUMATISM | 3544 | 3% | 0% | 43 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | INFLIXIMAB | 228399 | 11% | 7% | 175 | Search INFLIXIMAB | Search INFLIXIMAB |
2 | ETANERCEPT | 157657 | 7% | 8% | 104 | Search ETANERCEPT | Search ETANERCEPT |
3 | ADALIMUMAB | 152030 | 6% | 8% | 93 | Search ADALIMUMAB | Search ADALIMUMAB |
4 | DRUG INDUCED LUPUS | 140513 | 2% | 29% | 24 | Search DRUG+INDUCED+LUPUS | Search DRUG+INDUCED+LUPUS |
5 | HSPA12B | 108931 | 0% | 78% | 7 | Search HSPA12B | Search HSPA12B |
6 | HEAT SHOCK PROTEIN A12B | 100042 | 0% | 100% | 5 | Search HEAT+SHOCK+PROTEIN+A12B | Search HEAT+SHOCK+PROTEIN+A12B |
7 | TNF ALPHA ANTAGONISTS | 82050 | 1% | 22% | 19 | Search TNF+ALPHA+ANTAGONISTS | Search TNF+ALPHA+ANTAGONISTS |
8 | IMMUNOMEDIATED HEPATITIS | 60025 | 0% | 100% | 3 | Search IMMUNOMEDIATED+HEPATITIS | Search IMMUNOMEDIATED+HEPATITIS |
9 | INFLAMMATION AMPLIFIER | 60025 | 0% | 100% | 3 | Search INFLAMMATION+AMPLIFIER | Search INFLAMMATION+AMPLIFIER |
10 | RHEUMATOID ARTHRITIS | 54101 | 15% | 1% | 232 | Search RHEUMATOID+ARTHRITIS | Search RHEUMATOID+ARTHRITIS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SOLOMON, AJ , SPAIN, RI , KRUER, MC , BOURDETTE, D , (2011) INFLAMMATORY NEUROLOGICAL DISEASE IN PATIENTS TREATED WITH TUMOR NECROSIS FACTOR ALPHA INHIBITORS.MULTIPLE SCLEROSIS JOURNAL. VOL. 17. ISSUE 12. P. 1472 -1487 | 54 | 70% | 27 |
2 | SIMON, TA , THOMPSON, A , GANDHI, KK , HOCHBERG, MC , SUISSA, S , (2015) INCIDENCE OF MALIGNANCY IN ADULT PATIENTS WITH RHEUMATOID ARTHRITIS: A META-ANALYSIS.ARTHRITIS RESEARCH & THERAPY. VOL. 17. ISSUE . P. - | 35 | 83% | 18 |
3 | JOYAU, C , VEYRAC, G , DIXNEUF, V , JOLLIET, P , (2012) ANTI-TUMOUR NECROSIS FACTOR ALPHA THERAPY AND INCREASED RISK OF DE NOVO PSORIASIS: IS IT REALLY A PARADOXICAL SIDE EFFECT?.CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. VOL. 30. ISSUE 5. P. 700-706 | 35 | 90% | 23 |
4 | YADLAPATI, S , EFTHIMIOU, P , (2016) AUTOIMMUNE/INFLAMMATORY ARTHRITIS ASSOCIATED LYMPHOMAS: WHO IS AT RISK?.BIOMED RESEARCH INTERNATIONAL. VOL. . ISSUE . P. - | 52 | 53% | 1 |
5 | GAYED, M , BERNATSKY, S , RAMSEY-GOLDMAN, R , CLARKE, AE , GORDON, C , (2009) LUPUS AND CANCER.LUPUS. VOL. 18. ISSUE 6. P. 479-485 | 45 | 68% | 41 |
6 | HUANG, WK , CHIOU, MJ , KUO, CF , LIN, YC , YU, KH , SEE, LC , (2014) NO OVERALL INCREASED RISK OF CANCER IN PATIENTS WITH RHEUMATOID ARTHRITIS: A NATIONWIDE DYNAMIC COHORT STUDY IN TAIWAN.RHEUMATOLOGY INTERNATIONAL. VOL. 34. ISSUE 10. P. 1379 -1386 | 30 | 91% | 7 |
7 | COLLAMER, AN , BATTAFARANO, DF , (2010) PSORIATIC SKIN LESIONS INDUCED BY TUMOR NECROSIS FACTOR ANTAGONIST THERAPY: CLINICAL FEATURES AND POSSIBLE IMMUNOPATHOGENESIS.SEMINARS IN ARTHRITIS AND RHEUMATISM. VOL. 40. ISSUE 3. P. 233 -240 | 38 | 64% | 84 |
8 | RAMOS-CASALS, M , BRITO-ZERON, P , MUNOZ, S , SORIA, N , GALIANA, D , BERTOLACCINI, L , CUADRADO, MJ , KHAMASHTA, MA , (2007) AUTOIMMUNE DISEASES INDUCED BY TNF-TARGETED THERAPIES - ANALYSIS OF 233 CASES.MEDICINE. VOL. 86. ISSUE 4. P. 242 -251 | 35 | 59% | 307 |
9 | PIETROSANTI, M , DI ROSA, R , DIAMANTI, AP , SALEMI, S , FANTO, M , PERAGALLO, MS , D'AMELIO, R , (2016) RISK OF MALIGNANCY IN PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS UNDER IMMUNOSUPPRESSIVE THERAPY: A SINGLE-CENTER EXPERIENCE.INTERNAL AND EMERGENCY MEDICINE. VOL. 11. ISSUE 1. P. 31 -40 | 31 | 72% | 2 |
10 | TURESSON, C , MATTESON, EL , (2013) MALIGNANCY AS A COMORBIDITY IN RHEUMATIC DISEASES.RHEUMATOLOGY. VOL. 52. ISSUE 1. P. 5 -14 | 45 | 53% | 21 |
Classes with closest relation at Level 2 |